Amprion announces SYNTap™ Biomarker Test for Alzheimer’s, Lewy Body Dementia & Parkinson’s.
FDA Grants Breakthrough Device Designation For Amprion’s PMCA Tests For Detection of Misfolded Alpha-Synuclein, Prion Known to Drive Parkinson’s
Stay ahead of the curve on the latest breakthroughs and testing availability.
Join the fight to end Alzheimer’s, Parkinson’s, and all brain diseases.
Amprion pioneers early detection to track the biomarkers of Parkinson’s, Alzheimer’s, and Lewy Body Dementia. Our test identifies the biomarkers long before symptoms. We consider all brain diseases exist on a spectrum called ParkinZheimer™.
AMPRION & SYNTap are registered trademarks of Amprion Inc. ©2007-2021 Amprion Inc. All rights reserved.
Privacy Policy | HIPAA PolicyAMPRION & SYNTap are registered trademarks of Amprion Inc. ©2007-2021 Amprion Inc. All rights reserved. | Privacy Policy
| HIPAA Policy
